Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Carcinoma

Explore clinical trials studying Pancreatic Carcinoma. Study availability and eligibility vary by location and protocol.

50 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Carcinoma trial results

Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details
Completed

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

NCT02676349

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Institut Bergonié Bordeaux, France
  • Polyclinique Bordeaux Nord Bordeaux, France
  • Hôpital Beaujon Clichy, France
  • Chu Colmar Colmar, France
View all 26 locations
View Trial Details
Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details

Related conditions